Algeria is close to achieving self-sufficiency in the production of medicines by 83 percent, as confirmed by the Quality Management Officer at the National Pharmaceuticals Agency, Dr. Khadija Bougherra.
The spokeswoman said in the radio forum, on Sunday, that Algeria has achieved remarkable development in the field of pharmaceutical production in recent years, noting that the rate of self-sufficiency in the needs of the national market has reached 83 percent, with expectations that it will rise thanks to the projects being completed and the policy adopted to support the pharmaceutical industry.
Bougherra explained that this progress comes as an embodiment of the directives of the President of the Republic aimed at achieving pharmaceutical sovereignty and enhancing health security, a vision that was reinforced by the establishment of the Ministry of Pharmaceutical Industry in 2020, in addition to the entry into service of the National Agency for Pharmaceutical Materials in the same year.
The official revealed that Algeria currently counts 233 pharmaceutical production units and factories, in addition to the Ministry of Pharmaceutical Industry’s approval of granting licenses to complete 100 new projects under implementation, which represents a third of the pharmaceutical factories present on the African continent.
She also pointed out that Algeria has more than 780 production lines for various types of medicines, including complex medicines, stressing that the country is the only country in Africa and the Arab world that produces insulin pens 100 percent locally, in addition to manufacturing about 54 types of cancer treatment medicines out of about 200 medicines registered within the national code for combating the disease.
Bougherra expected that the licenses granted to implement new projects to produce medicines would have a positive impact on the labor market, especially with the registration of projects to produce innovative medicines, in addition to a project to establish a center for biological research and vaccine production.
She also talked about a new project with the “Sidal Complex” in the field of cell therapy, which would enhance job opportunities and support innovation in the national pharmaceutical industry.
#Algeria #approaching #percent #pharmaceutical #sovereignty #Algeria
